Spok (SPOK) Expected to Announce Quarterly Earnings on Wednesday

Spok (NASDAQ:SPOK - Get Free Report) will likely be announcing its Q2 2025 earnings results before the market opens on Wednesday, July 23rd. Analysts expect the company to announce earnings of $0.18 per share and revenue of $35.00 million for the quarter. Spok has set its FY 2025 guidance at EPS.

Spok (NASDAQ:SPOK - Get Free Report) last issued its earnings results on Wednesday, April 30th. The Wireless communications provider reported $0.25 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.18 by $0.07. The company had revenue of $36.29 million during the quarter, compared to analyst estimates of $34.00 million. Spok had a net margin of 11.45% and a return on equity of 10.26%. On average, analysts expect Spok to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Spok Stock Down 1.7%

Shares of NASDAQ:SPOK traded down $0.30 during trading on Friday, reaching $17.37. 152,872 shares of the company traded hands, compared to its average volume of 120,771. The firm has a fifty day simple moving average of $16.89 and a 200 day simple moving average of $16.33. The firm has a market cap of $357.34 million, a P/E ratio of 22.27 and a beta of 0.58. Spok has a 1-year low of $13.55 and a 1-year high of $18.29.

Spok Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Friday, May 23rd were issued a dividend of $0.3125 per share. The ex-dividend date was Friday, May 23rd. This represents a $1.25 dividend on an annualized basis and a dividend yield of 7.20%. Spok's dividend payout ratio is currently 160.26%.

Wall Street Analyst Weigh In

Several brokerages recently commented on SPOK. Wall Street Zen upgraded shares of Spok from a "buy" rating to a "strong-buy" rating in a report on Saturday, May 10th. B. Riley upgraded shares of Spok to a "strong-buy" rating in a report on Thursday, May 1st.

Insider Transactions at Spok

In related news, COO Michael W. Wallace sold 6,000 shares of the business's stock in a transaction that occurred on Wednesday, May 7th. The shares were sold at an average price of $16.53, for a total transaction of $99,180.00. Following the completion of the sale, the chief operating officer directly owned 61,175 shares of the company's stock, valued at $1,011,222.75. The trade was a 8.93% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CEO Vincent D. Kelly sold 30,000 shares of the company's stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $16.40, for a total transaction of $492,000.00. Following the completion of the sale, the chief executive officer directly owned 157,817 shares of the company's stock, valued at $2,588,198.80. The trade was a 15.97% decrease in their position. The disclosure for this sale can be found here. 7.37% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the business. AQR Capital Management LLC bought a new position in Spok during the first quarter worth about $271,000. Goldman Sachs Group Inc. increased its position in Spok by 33.4% during the first quarter. Goldman Sachs Group Inc. now owns 521,571 shares of the Wireless communications provider's stock worth $8,575,000 after acquiring an additional 130,478 shares during the period. Finally, Jane Street Group LLC bought a new position in Spok during the first quarter worth about $467,000. Institutional investors and hedge funds own 50.81% of the company's stock.

Spok Company Profile

Spok Holdings, Inc, through its subsidiary, Spok, Inc, provides healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. The company's products and services enhance workflows for clinicians and support administrative compliance. It delivers clinical information to care teams when and where it matters to enhance patient outcomes; and provides GenA Pager, a one-way alphanumeric pager.